Literature DB >> 27957217

Ischemic Stroke: Risk Stratification, Warfarin Teatment and Outcome Measure.

Srikanth Kaithoju1.   

Abstract

Stroke is a focal neurological syndrome of vascular basis, which may be due to ischemic thrombo-embolism or intra-cerebral haemorrhage. This condition has to be treated on emergency basis as it may cause an irreversible neurological damage. Warfarin has been a widely used oral anti-coagulant in treating ischemic stroke patients. This review highlights the benefits and challenges of warfarin treatment in stroke patients and discusses about the importance of risk stratification scores and bleeding scores in estimating the bleeding risk associated with warfarin treatment. This review also highlights the use of stroke outcome measures in identifying the patients with post-stroke disabilities to provide patient specific treatment.

Entities:  

Keywords:  Ischemic Stroke; Risk Stratification Schemes; Stroke; Stroke Outcome Measures; Stroke Outcomes; Warfarin Treatment

Year:  2015        PMID: 27957217      PMCID: PMC5135176          DOI: 10.4022/jafib.1144

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  43 in total

Review 1.  A practical review of the Glasgow Coma Scale and Score.

Authors:  Philip Barlow
Journal:  Surgeon       Date:  2012-01-31       Impact factor: 2.392

Review 2.  The Glasgow Coma Scale--a brief review. Past, present, future.

Authors:  Georgios Matis; Theodossios Birbilis
Journal:  Acta Neurol Belg       Date:  2008-09       Impact factor: 2.396

Review 3.  Ineligibility for anticoagulation in patients with atrial fibrillation.

Authors:  Ian del Conde; Jonathan L Halperin
Journal:  Am J Med       Date:  2013-02       Impact factor: 4.965

4.  Diabetes worsens the outcome of acute ischemic stroke.

Authors:  Minna M Kaarisalo; Ismo Räihä; Juhani Sivenius; Pirjo Immonen-Räihä; Aapo Lehtonen; Cinzia Sarti; Markku Mähönen; Jorma Torppa; Jaakko Tuomilehto; Veikko Salomaa
Journal:  Diabetes Res Clin Pract       Date:  2005-03-16       Impact factor: 5.602

Review 5.  Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.

Authors:  Ricarda Marinigh; Gregory Y H Lip; Nicola Fiotti; Carlo Giansante; Deirdre A Lane
Journal:  J Am Coll Cardiol       Date:  2010-09-07       Impact factor: 24.094

6.  Outcome and risk factors presented in old patients above 80 years of age versus younger patients after ischemic stroke.

Authors:  Line Bentsen; Louisa Christensen; Anders Christensen; Hanne Christensen
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-05-01       Impact factor: 2.136

7.  Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.

Authors:  Gregory Y H Lip
Journal:  Am J Med       Date:  2010-09-29       Impact factor: 4.965

8.  Relationship between the Oxfordshire Community Stroke Project classification and vascular abnormalities in patients with predominantly intracranial atherosclerosis.

Authors:  Huan Li; Ka Sing Wong; Richard Kay
Journal:  J Neurol Sci       Date:  2003-03-15       Impact factor: 3.181

Review 9.  Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.

Authors:  Mark J Alberts; John W Eikelboom; Graeme J Hankey
Journal:  Lancet Neurol       Date:  2012-12       Impact factor: 44.182

Review 10.  Prevention of stroke in patients with hypertension.

Authors:  Björn Dahlöf
Journal:  Am J Cardiol       Date:  2007-05-25       Impact factor: 2.778

View more
  7 in total

Review 1.  Role of PFO Closure in Ischemic Stroke Prevention.

Authors:  Nicholas D Osteraas; Alejandro Vargas; Laurel Cherian; Sarah Song
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

2.  The efficacy and safety of thrombolytic agents for patients with cerebral infarction: A protocol for systematic review and network meta-analysis.

Authors:  Shenghui Huang; Junshi Jiang; Zhiming Xu; Cuncun Lu; Fang Cao; Wengxia Sang; Ting Gong; Yanyi Li
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  Interactive Association Between CYP2C9 rs2860905 Polymorphism and Atrial Fibrillation on Ischemic Stroke in Taiwan Biobank Participants.

Authors:  Jui-Wen Peng; Oswald Ndi Nfor; Chien-Chang Ho; Shu-Yi Hsu; Chia-Chi Lung; Disline Manli Tantoh; Ming-Chih Chou; Yung-Po Liaw
Journal:  Pharmgenomics Pers Med       Date:  2021-08-31

Review 4.  Oxidative Injury in Ischemic Stroke: A Focus on NADPH Oxidase 4.

Authors:  Ganglei Li; Changsheng Ye; Yu Zhu; Tiesong Zhang; Jun Gu; Jianwei Pan; Feng Wang; Fan Wu; Kaiyuan Huang; Kangli Xu; Xiaomin Wu; Jian Shen
Journal:  Oxid Med Cell Longev       Date:  2022-02-03       Impact factor: 6.543

5.  Independent and Interactive Effects of Sex and CYP2C9 Variant rs4918758 on Ischemic Stroke Risk in Taiwan Biobank.

Authors:  Jui-Wen Peng; Oswald Ndi Nfor; Chien-Chang Ho; Shu-Yi Hsu; Ming-Chih Chou; Yung-Po Liaw
Journal:  Int J Gen Med       Date:  2022-04-01

6.  Comparison of Two Software Packages for Perfusion Imaging: Ischemic Core and Penumbra Estimation and Patient Triage in Acute Ischemic Stroke.

Authors:  Xiang Zhou; Yashi Nan; Jieyang Ju; Jingyu Zhou; Huanhui Xiao; Silun Wang
Journal:  Cells       Date:  2022-08-16       Impact factor: 7.666

7.  Clinical Efficacy Evaluation and Potential Mechanism of Zhishe Tongluo Capsule in the Treatment of Cerebral Infarction by Meta-Analysis Associated with Network Pharmacology.

Authors:  Zhi Xin Geng; Feng Gao; Junjing Guo; Bingzhou Guo; Chunyu Liu; Taiwei Dong; Min Li; Yang Bai; Peifeng Wei
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-10       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.